MRPL36
geneOn this page
Also known as RPMJL36mtPRPL36MRP-L36bL36m
Summary
MRPL36 (mitochondrial ribosomal protein L36, HGNC:14490) is a protein-coding gene on chromosome 5p15.33, encoding Large ribosomal subunit protein bL36m (Q9P0J6). It is a selective cancer dependency (DepMap: 58.0% of cell lines).
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. A pseudogene corresponding to this gene is found on chromosome 2p.
Source: NCBI Gene 64979 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 50 total
- Cancer dependency (DepMap): dependent in 58.0% of screened cell lines
- MANE Select transcript:
NM_032479
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14490 |
| Approved symbol | MRPL36 |
| Name | mitochondrial ribosomal protein L36 |
| Location | 5p15.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RPMJ, L36mt, PRPL36, MRP-L36, bL36m |
| Ensembl gene | ENSG00000171421 |
| Ensembl biotype | protein_coding |
| OMIM | 611842 |
| Entrez | 64979 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 11 protein_coding
ENST00000382647, ENST00000505059, ENST00000505818, ENST00000508987, ENST00000510999, ENST00000887752, ENST00000887753, ENST00000887754, ENST00000933972, ENST00000933973, ENST00000933974
RefSeq mRNA: 1 — MANE Select: NM_032479
NM_032479
CCDS: CCDS3865
Canonical transcript exons
ENST00000505059 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002077583 | 1799792 | 1799837 |
| ENSE00003842015 | 1798385 | 1798947 |
Expression profiles
Bgee: expression breadth ubiquitous, 255 present calls, max score 99.44.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 23.8682 / max 188.9301, expressed in 1801 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 60825 | 15.0525 | 1782 |
| 60826 | 5.1578 | 1662 |
| 60824 | 3.0758 | 1504 |
| 60827 | 0.4618 | 281 |
| 60828 | 0.1203 | 26 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| pancreatic ductal cell | CL:0002079 | 99.44 | gold quality |
| tibialis anterior | UBERON:0001385 | 98.65 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 98.12 | gold quality |
| quadriceps femoris | UBERON:0001377 | 97.99 | gold quality |
| vastus lateralis | UBERON:0001379 | 97.90 | gold quality |
| deltoid | UBERON:0001476 | 97.74 | gold quality |
| ileal mucosa | UBERON:0000331 | 97.53 | gold quality |
| biceps brachii | UBERON:0001507 | 97.44 | gold quality |
| left testis | UBERON:0004533 | 97.26 | gold quality |
| right testis | UBERON:0004534 | 97.05 | gold quality |
| kidney epithelium | UBERON:0004819 | 96.98 | gold quality |
| adult organism | UBERON:0007023 | 96.98 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 96.96 | gold quality |
| gastrocnemius | UBERON:0001388 | 96.80 | gold quality |
| myocardium | UBERON:0002349 | 96.78 | gold quality |
| heart right ventricle | UBERON:0002080 | 96.56 | gold quality |
| testis | UBERON:0000473 | 96.55 | gold quality |
| muscle of leg | UBERON:0001383 | 96.49 | gold quality |
| body of tongue | UBERON:0011876 | 96.42 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 96.27 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 96.12 | gold quality |
| upper arm skin | UBERON:0004263 | 96.10 | gold quality |
| sperm | CL:0000019 | 96.03 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 96.03 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 95.96 | gold quality |
| muscle tissue | UBERON:0002385 | 95.87 | gold quality |
| cardiac ventricle | UBERON:0002082 | 95.30 | gold quality |
| heart left ventricle | UBERON:0002084 | 95.30 | gold quality |
| gingiva | UBERON:0001828 | 95.25 | gold quality |
| parotid gland | UBERON:0001831 | 95.23 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.73 |
| E-GEOD-124858 | no | 165.41 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
16 targeting MRPL36, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-4713-5P | 99.78 | 67.80 | 1794 |
| HSA-MIR-33A-3P | 99.70 | 70.27 | 3362 |
| HSA-MIR-5093 | 99.67 | 69.26 | 2291 |
| HSA-MIR-6740-3P | 99.48 | 68.49 | 1392 |
| HSA-MIR-6868-3P | 98.63 | 69.64 | 2259 |
| HSA-MIR-3689F | 98.35 | 70.08 | 1052 |
| HSA-MIR-3689A-5P | 98.35 | 70.12 | 1049 |
| HSA-MIR-3689B-5P | 98.35 | 70.12 | 1049 |
| HSA-MIR-3689E | 98.35 | 70.12 | 1049 |
| HSA-MIR-6867-3P | 98.12 | 66.07 | 1305 |
| HSA-MIR-493-3P | 97.50 | 66.44 | 731 |
| HSA-MIR-514A-5P | 96.94 | 65.49 | 801 |
| HSA-MIR-4522 | 95.76 | 66.23 | 742 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 58.0% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 1)
- MRPL36 contributes to the regulation of mitochondrial ATP production and necrotic cell death. (PMID:19318571)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mrpl36 | ENSDARG00000070607 |
| mus_musculus | Mrpl36 | ENSMUSG00000021607 |
| rattus_norvegicus | Mrpl36 | ENSRNOG00000023407 |
| drosophila_melanogaster | mRpL36 | FBGN0042112 |
| caenorhabditis_elegans | WBGENE00010783 |
Protein
Protein identifiers
Large ribosomal subunit protein bL36m — Q9P0J6 (reviewed: Q9P0J6)
Alternative names: 39S ribosomal protein L36, mitochondrial, BRCA1-interacting protein 1
All UniProt accessions (2): D6RB74, Q9P0J6
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Component of the mitochondrial large ribosomal subunit (mt-LSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins. bL36m has a zinc binding site.
Subcellular location. Mitochondrion.
Similarity. Belongs to the bacterial ribosomal protein bL36 family.
RefSeq proteins (1): NP_115868* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000473 | Ribosomal_bL36 | Family |
| IPR035977 | Ribosomal_bL36_sp | Homologous_superfamily |
| IPR052143 | Mitoribosomal_bL36m | Family |
Pfam: PF00444
UniProt features (7 total): strand 3, transit peptide 1, chain 1, sequence conflict 1, helix 1
Structure
Experimental structures (PDB)
73 structures, top 30 by resolution.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7OF0 | ELECTRON MICROSCOPY | 2.2 |
| 7QI4 | ELECTRON MICROSCOPY | 2.21 |
| 8RRI | ELECTRON MICROSCOPY | 2.4 |
| 9OLF | ELECTRON MICROSCOPY | 2.46 |
| 7OF7 | ELECTRON MICROSCOPY | 2.5 |
| 6ZM6 | ELECTRON MICROSCOPY | 2.59 |
| 7O9M | ELECTRON MICROSCOPY | 2.6 |
| 7OF6 | ELECTRON MICROSCOPY | 2.6 |
| 9CN3 | ELECTRON MICROSCOPY | 2.62 |
| 7QI5 | ELECTRON MICROSCOPY | 2.63 |
| 7OF2 | ELECTRON MICROSCOPY | 2.7 |
| 7OF3 | ELECTRON MICROSCOPY | 2.7 |
| 7OF4 | ELECTRON MICROSCOPY | 2.7 |
| 9PR4 | ELECTRON MICROSCOPY | 2.77 |
| 9PRA | ELECTRON MICROSCOPY | 2.83 |
| 8ANY | ELECTRON MICROSCOPY | 2.85 |
| 6ZM5 | ELECTRON MICROSCOPY | 2.89 |
| 7QH7 | ELECTRON MICROSCOPY | 2.89 |
| 7ODR | ELECTRON MICROSCOPY | 2.9 |
| 7OF5 | ELECTRON MICROSCOPY | 2.9 |
| 8K2A | ELECTRON MICROSCOPY | 2.9 |
| 8OIT | ELECTRON MICROSCOPY | 2.9 |
| 9PGL | ELECTRON MICROSCOPY | 2.9 |
| 9PGF | ELECTRON MICROSCOPY | 2.93 |
| 6VMI | ELECTRON MICROSCOPY | 2.96 |
| 6VLZ | ELECTRON MICROSCOPY | 2.97 |
| 7QI6 | ELECTRON MICROSCOPY | 2.98 |
| 9PSM | ELECTRON MICROSCOPY | 2.98 |
| 8QSJ | ELECTRON MICROSCOPY | 3 |
| 9UWH | ELECTRON MICROSCOPY | 3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9P0J6-F1 | 73.15 | 0.41 |
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-5368286 | Mitochondrial translation initiation |
| R-HSA-5389840 | Mitochondrial translation elongation |
| R-HSA-5419276 | Mitochondrial translation termination |
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-5368287 | Mitochondrial translation |
| R-HSA-72766 | Translation |
MSigDB gene sets: 144 (showing top):
MODULE_255, GOBP_MITOCHONDRIAL_TRANSLATION, MODULE_317, GOBP_TRANSLATION, WEI_MYCN_TARGETS_WITH_E_BOX, GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME, GOCC_MITOCHONDRIAL_ENVELOPE, NIKOLSKY_BREAST_CANCER_5P15_AMPLICON, GARY_CD5_TARGETS_DN, WONG_MITOCHONDRIA_GENE_MODULE, MODULE_207, ZHOU_TNF_SIGNALING_30MIN, GOCC_LARGE_RIBOSOMAL_SUBUNIT, GOCC_RIBOSOME, GOCC_ORGANELLAR_RIBOSOME
GO Biological Process (2): translation (GO:0006412), mitochondrial translation (GO:0032543)
GO Molecular Function (2): structural constituent of ribosome (GO:0003735), protein binding (GO:0005515)
GO Cellular Component (6): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial large ribosomal subunit (GO:0005762), nuclear body (GO:0016604), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
| Translation | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membraneless organelle | 2 |
| peptidyltransferase activity | 1 |
| translational initiation | 1 |
| translational elongation | 1 |
| translational termination | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| mitochondrion | 1 |
| translation | 1 |
| mitochondrial gene expression | 1 |
| structural molecule activity | 1 |
| ribosome | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar large ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| nucleoplasm | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
2935 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRPL36 | MRPL17 | Q9NRX2 | 647 |
| MRPL36 | MRPL1 | Q9BYD6 | 646 |
| MRPL36 | MRPL24 | Q96A35 | 628 |
| MRPL36 | MRPS16 | Q9Y3D3 | 627 |
| MRPL36 | MRPL11 | Q9Y3B7 | 626 |
| MRPL36 | MRPL12 | P52815 | 595 |
| MRPL36 | MRPL21 | Q7Z2W9 | 595 |
| MRPL36 | LETM1 | O95202 | 593 |
| MRPL36 | MRPS11 | P82912 | 572 |
| MRPL36 | MRPL9 | Q9BYD2 | 530 |
| MRPL36 | RPL36 | Q9Y3U8 | 529 |
| MRPL36 | MRPL13 | Q9BYD1 | 528 |
| MRPL36 | MRPL4 | Q9BYD3 | 526 |
| MRPL36 | MRPL19 | P49406 | 524 |
| MRPL36 | MRPS10 | P82664 | 513 |
IntAct
14 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MRPL36 | CIDEB | psi-mi:“MI:0915”(physical association) | 0.560 |
| NDUFAB1 | MIEF1 | psi-mi:“MI:0915”(physical association) | 0.490 |
| MRPL36 | E7 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PIPSL | C1orf226 | psi-mi:“MI:0914”(association) | 0.350 |
| FTL | SH3PXD2B | psi-mi:“MI:0914”(association) | 0.350 |
| PSME3 | ZNF891 | psi-mi:“MI:0914”(association) | 0.350 |
| FTL | psi-mi:“MI:0914”(association) | 0.350 | |
| GADD45GIP1 | psi-mi:“MI:0915”(physical association) | 0.320 | |
| MRPL18 | psi-mi:“MI:0915”(physical association) | 0.320 | |
| RRAS | MRPL36 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MRPL36 | CIDEB | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (28): MRPL36 (Positive Genetic), MRPL36 (Negative Genetic), MRPL36 (Negative Genetic), MRPL36 (Positive Genetic), MRPL36 (Negative Genetic), MRPL36 (Negative Genetic), MRPL36 (Negative Genetic), MRPL36 (Positive Genetic), MRPL36 (Positive Genetic), MRPL42 (Positive Genetic), MRPS21 (Positive Genetic), MRPS35 (Positive Genetic), MRPS5 (Positive Genetic), GATB (Positive Genetic), TAZ (Negative Genetic)
ESM2 similar proteins: A6ZR01, A6ZRW2, A8NN94, B2RZ39, B3LS63, B5VHI3, F5HIJ5, G2TRP2, O13744, O13882, O14464, O74464, O94379, O94690, P12629, P25348, P25642, P32344, P32611, P36520, P36525, P36526, P38064, P38175, P40033, P42797, P42844, P49391, P53921, P82244, Q04598, Q09759, Q0E959, Q1K7P9, Q1LWG3, Q21454, Q54WP3, Q61JI9, Q6BIJ5, Q84JG5
Diamond homologs: A1BJ11, A1JS06, A2RC37, A4SCT2, A4WFA7, A5IMA7, A5VLI2, A6LLN7, A7HM28, A7MPF5, A7ZSI8, A8A5A4, A8F4T5, A9BFZ4, B1IQ00, B1JIY2, B1LBL6, B1LHB3, B1X6F1, B2G8V5, B2K516, B2RZ39, B3DFA8, B3EGW7, B3EP38, B3QR94, B3QYE6, B3WAJ5, B4F1K5, B4RT49, B4S5A5, B4SBX0, B4U523, B5XJ59, B7K227, B7KI08, B9DSX3, C0M6X5, C0ME28, C1BJQ3
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MRPL36 | “form complex” | “39S mitochondrial large ribosomal subunit” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
50 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 34 |
| Likely benign | 8 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
481 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:1798948:C:CC | acceptor_gain | 1.0000 |
| 5:1798943:TGAAT:T | acceptor_gain | 0.9900 |
| 5:1798946:AT:A | acceptor_gain | 0.9900 |
| 5:1798947:TCTA:T | acceptor_loss | 0.9900 |
| 5:1798948:CTATG:C | acceptor_loss | 0.9900 |
| 5:1798950:A:C | acceptor_gain | 0.9900 |
| 5:1798944:GAAT:G | acceptor_gain | 0.9800 |
| 5:1801546:CCAGG:C | donor_loss | 0.9800 |
| 5:1801547:CAGG:C | donor_loss | 0.9800 |
| 5:1801548:AG:A | donor_loss | 0.9800 |
| 5:1801550:G:A | donor_loss | 0.9800 |
| 5:1801551:T:A | donor_loss | 0.9800 |
| 5:1798945:AAT:A | acceptor_gain | 0.9700 |
| 5:1799791:CCCGG:C | donor_gain | 0.9700 |
| 5:1801533:TC:T | donor_gain | 0.9700 |
| 5:1798950:A:AC | acceptor_gain | 0.9600 |
| 5:1799785:C:CA | donor_gain | 0.9600 |
| 5:1799787:CTTA:C | donor_loss | 0.9600 |
| 5:1799790:A:C | donor_loss | 0.9600 |
| 5:1801671:T:TA | donor_gain | 0.9500 |
| 5:1799496:TGCGG:T | donor_gain | 0.9400 |
| 5:1799790:AC:A | donor_gain | 0.9400 |
| 5:1799791:CC:C | donor_gain | 0.9400 |
| 5:1801534:C:A | donor_gain | 0.9400 |
| 5:1801777:G:T | donor_gain | 0.9400 |
| 5:1801556:GCCGC:G | donor_gain | 0.9300 |
| 5:1799790:A:AC | donor_gain | 0.9200 |
| 5:1799791:C:CC | donor_gain | 0.9200 |
| 5:1799792:C:G | donor_loss | 0.9000 |
| 5:1801672:T:TA | donor_gain | 0.9000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000952760 (5:1799340 C>A,T), RS1001074191 (5:1800857 T>G), RS1001375025 (5:1801508 C>G,T), RS1001422176 (5:1800551 G>C,T), RS1001783800 (5:1801736 G>A), RS1001884642 (5:1798478 A>C,G), RS1001959970 (5:1800098 T>G), RS1003153395 (5:1802405 G>A), RS1003248583 (5:1801314 C>G), RS1003422621 (5:1801307 TCCCCGCC>T,TCCCCGCCCCCCGCC), RS1003453227 (5:1802676 C>T), RS1003559103 (5:1799416 C>T), RS10037336 (5:1800024 C>G,T), RS1003887921 (5:1802628 T>A), RS1004422841 (5:1799873 G>A)
Disease associations
OMIM: gene MIM:611842 | disease phenotypes: MIM:618232, MIM:252010
GenCC curated gene-disease
Mondo (3): mitochondrial complex I deficiency, nuclear type 9 (MONDO:0032615), mitochondrial complex I deficiency, nuclear type 1 (MONDO:0100224), mitochondrial complex I deficiency (MONDO:0100133)
Orphanet (1): Isolated complex I deficiency (Orphanet:2609)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006609_2 | Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count) | 4.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004653 | response to TNF antagonist |
| EFO:0005413 | joint damage measurement |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C537475 | Mitochondrial complex I deficiency (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression, increases methylation | 4 |
| sodium arsenite | decreases expression, increases expression | 2 |
| Air Pollutants | affects expression, increases abundance, decreases expression | 2 |
| bisphenol A | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| chloropicrin | decreases expression | 1 |
| Vorinostat | increases expression | 1 |
| Acetaminophen | affects cotreatment, decreases expression | 1 |
| Atrazine | decreases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Lipopolysaccharides | affects cotreatment, decreases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Nanotubes, Carbon | increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
1 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT05162768 | PHASE3 | COMPLETED | Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD) |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): mitochondrial complex I deficiency, mitochondrial complex I deficiency, nuclear type 1, mitochondrial complex I deficiency, nuclear type 9